Acadian Asset Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $687K | Sell |
491,943
-12,095
| -2% | -$16.9K | ﹤0.01% | 1071 |
|
|
2025
Q1 | $810K | Buy |
504,038
+4,778
| +1% | +$7.68K | ﹤0.01% | 978 |
|
|
2024
Q4 | $628K | Buy |
499,260
+45,566
| +10% | +$57.3K | ﹤0.01% | 1025 |
|
|
2024
Q3 | $851K | Buy |
+453,694
| New | +$851K | ﹤0.01% | 957 |
|
|
2023
Q1 | – | Sell |
-25,693
| Closed | -$273K | – | 1737 |
|
|
2022
Q4 | $273K | Buy |
25,693
+9,930
| +63% | +$106K | ﹤0.01% | 1210 |
|
|
2022
Q3 | $115K | Buy |
+15,763
| New | +$115K | ﹤0.01% | 1332 |
|